Literature DB >> 6772735

Biogenesis of membrane-bound and secreted immunoglobulins. I. Two distinct translation products of human mu-chain, with identical N-termini and different C-termini.

J M McCune, V R Lingappa, S M Fu, G Blobel, H G Kunkel.   

Abstract

Structural differences between the heavy chain of membrane-bound IgM (mu m) and the heavy chain of secreted IgM (mu s) were investigated. The primary translation products of the mu-chain, free of posttranslational modifications, were synthesized in a wheat-germ cell-free system, programmed with messenger RNA derived from human lymphoblastoid cell lines positive for both membrane-bound and secreted IgM. Encoded in this sytem were two mu-chains, which shared N-terminal signal peptides and which differed both in molecular weight and in C-terminal amino acid sequence. In vivo pulse labeling of cells confirmed that, as intermediates in the rough endoplasmic reticulum, these two forms expressed the same idiotype and maintained their difference in molecular weight and in C-terminal sequence. By correlation with pulse-chase kinetics and with immunofluorescence, one form of mu-chain represents mu m, and the other, mu s. Because the molecular weight difference between the two is manifest at the level of their primary translation products, these studies demonstrate that mu m is distinguished from mu s by a difference in primary structure, at least in part at the C-terminus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772735      PMCID: PMC2185946          DOI: 10.1084/jem.152.2.463

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Are immunoglobulins integral membrane proteins?

Authors:  U Melcher; L Eidels; J W Uhr
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

2.  mu-Chains from a nonsecretor B cell line differ from secreted mu-chains at the C-terminal end.

Authors:  P B Williams; R T Kubo; H M Grey
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

3.  A signal sequence for the insertion of a transmembrane glycoprotein. Similarities to the signals of secretory proteins in primary structure and function.

Authors:  V R Lingappa; F N Katz; H F Lodish; G Blobel
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

4.  Evidence for a C-terminal tyrosine residue in human and mouse B-lymphocyte membrane mu chains.

Authors:  R A McIlhinney; N E Richardson; A Feinstein
Journal:  Nature       Date:  1978-04-06       Impact factor: 49.962

5.  IgM in bone marrow-derived lymphocytes. Synthesis, surface deposition, turnover and carbohydrate composition in unstimulated mouse B cells.

Authors:  J Andersson; L Lafleur
Journal:  Eur J Immunol       Date:  1974-03       Impact factor: 5.532

6.  Carboxypeptidase from yeast. Large scale preparation and the application to COOH-terminal analysis of peptides and proteins.

Authors:  R Hayashi; S Moore; W H Stein
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

7.  Complete amino acid sequence of the Mu heavy chain of a human IgM immunoglobulin.

Authors:  F W Putnam; G Florent; C Paul; T Shinoda; A Shimizu
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

8.  Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Functional interaction of plant ribosomes with animal microsomal membranes.

Authors:  B Dobberstein; G Blobel
Journal:  Biochem Biophys Res Commun       Date:  1977-02-21       Impact factor: 3.575

10.  Cell surface immunoglobulin. XVI. Polypeptide chain structure of mouse IgM and IgD-like molecule.

Authors:  U Melcher; J W Uhr
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

View more
  16 in total

Review 1.  Intracellular traffic of newly synthesized proteins. Current understanding and future prospects.

Authors:  V R Lingappa
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

2.  Study of proteolytic removal of Fab delta and Fe delta determinants of lymphocyte membrane IgD using a direct rosette assay.

Authors:  J E Calvert; N R Ling; R Jefferis
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

Review 3.  Transport models for secretory IgA and secretory IgM.

Authors:  P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

4.  Synthesis and processing of the alpha heavy chains of secreted and membrane-bound IgA.

Authors:  H Kikutani; R Sitia; R A Good; J Stavnezer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  Biogenesis of membrane-bound and secreted immunoglobulins: two primary translation products of the human delta chain, differentially N-glycosylated to four discrete forms in vivo and in vitro.

Authors:  J M McCune; S M Fu; H G Kunkel; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Biosynthesis and structure of membrane and secretory immunoglobulins.

Authors:  H P Kocher; R K Bijlenga; J C Jaton
Journal:  Mol Cell Biochem       Date:  1982-08-20       Impact factor: 3.396

7.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Rat liver asialoglycoprotein receptor lacks a cleavable NH2-terminal signal sequence.

Authors:  E C Holland; J O Leung; K Drickamer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Productive infection of cultured human lymphoid cells by adenovirus.

Authors:  D Lavery; S M Fu; T Lufkin; S Chen-Kiang
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

10.  Differential regulation of membrane and secretory mu chain synthesis in human beta cell lines. Regulation of membrane mu or secreted mu.

Authors:  L Hendershot; D Levitt
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.